Synchrotron X-ray fluorescence studies of a bromine-labelled cyclic RGD peptide interacting with individual tumor cells.
Erin J Sheridan, Christopher J D Austin, Jade B Aitken, Stefan Vogt, Katrina A Jolliffe, Hugh H Harris, Louis M Rendina
Index: J. Synchrotron Radiat. 20(Pt 2) , 226-33, (2013)
Full Text: HTML
Abstract
The first example of synchrotron X-ray fluorescence imaging of cultured mammalian cells in cyclic peptide research is reported. The study reports the first quantitative analysis of the incorporation of a bromine-labelled cyclic RGD peptide and its effects on the biodistribution of endogenous elements (for example, K and Cl) within individual tumor cells.
Related Compounds
Related Articles:
Spontaneous transfer of chirality in an atropisomerically enriched two-axis system.
2014-05-01
[Nature 509(7498) , 71-5, (2014)]
2014-09-24
[ACS Appl. Mater. Interfaces 6(18) , 15774-82, (2014)]
2014-12-01
[J. Enzyme Inhib. Med. Chem. 29(6) , 846-67, (2014)]
2015-01-01
[Anal. Bioanal. Chem 407(3) , 973-81, (2015)]
2013-02-01
[ChemSusChem 6(2) , 328-35, (2013)]